Vibhavadi Medical Center Valuation

Q: What is the Fair Price of VIBHA-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

VIBHA-R (THB2.04) is trading above our estimate of [[fair value]] (THB1.49)

Is VIBHA-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VIBHA-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VIBHA-R (THB2.04) is trading above our estimate of fair value (THB1.49)

Significantly Below Fair Value: VIBHA-R is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VIBHA-R?

Key metric: As VIBHA-R is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for VIBHA-R. This is calculated by dividing VIBHA-R's market cap by their current earnings.
What is VIBHA-R's PE Ratio?
PE Ratio	26.9x
Earnings	฿1.02b
Market Cap	฿27.51b

VIBHA-R key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	4.3x
Enterprise Value/EBITDA	18.6x
PEG Ratio	2.3x

Price to Earnings Ratio vs Peers

How does VIBHA-R's PE Ratio compare to its peers?

The above table shows the PE ratio for VIBHA-R vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	24.7x
RAM Ramkhamhaeng Hospital	21.6x	16.2%	฿28.0b
SKR Sikarin	22.8x	n/a	฿19.2b
CHG Chularat Hospital	25.3x	9.5%	฿29.0b
PR9 Praram 9 Hospital	29.2x	11.3%	฿20.2b
VIBHA-R Vibhavadi Medical Center	26.9x	11.8%	฿27.5b

Price-To-Earnings vs Peers: VIBHA-R is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the peer average (24.7x).

Price to Earnings Ratio vs Industry

How does VIBHA-R's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: VIBHA-R is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the TH Healthcare industry average (21.5x).

Price to Earnings Ratio vs Fair Ratio

What is VIBHA-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VIBHA-R PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	26.9x
Fair PE Ratio	24.8x

Price-To-Earnings vs Fair Ratio: VIBHA-R is expensive based on its Price-To-Earnings Ratio (26.9x) compared to the estimated Fair Price-To-Earnings Ratio (24.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Safe Fertility Group

฿3.7b

Provides fertility medical center services in Thailand.

SAFE-R

฿12.30

2.5%

-28.1%

Master Style

฿13.0b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿43.50

3.0%

-7.9%

E for L Aim

฿1.1b

Engages in the distribution of medical devices and equipment in Thailand.

EFORL-R

฿0.27

-3.6%

3.8%